Yubo International Biotech Ltd Quarterly Operating Income (Loss) in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Yubo International Biotech Ltd quarterly/annual Operating Income (Loss) history and growth rate from Q4 2010 to Q3 2024.
  • Yubo International Biotech Ltd Operating Income (Loss) for the quarter ending September 30, 2024 was -$533K, a 8395% decline year-over-year.
  • Yubo International Biotech Ltd Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.93M, a 236% decline year-over-year.
  • Yubo International Biotech Ltd annual Operating Income (Loss) for 2023 was -$1.19M, a 0.87% increase from 2022.
  • Yubo International Biotech Ltd annual Operating Income (Loss) for 2022 was -$1.21M, a 21.9% increase from 2021.
  • Yubo International Biotech Ltd annual Operating Income (Loss) for 2021 was -$1.54M, a 117% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.93M -$533K -$539K -8395% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$1.39M -$470K -$103K -28.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$1.29M -$409K -$92.9K -29.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$1.19M -$517K -$621K -600% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-12
Q3 2023 -$574K $6.42K +$245K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$819K -$367K +$124K +25.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$943K -$317K +$262K +45.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$1.21M $103K +$492K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 -$1.7M -$238K +$108K +31.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$1.8M -$492K -$121K -32.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$1.68M -$579K -$140K -32% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.54M -$388K -$363K -1423% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$1.18M -$346K -$41.5K -13.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-16
Q2 2021 -$1.14M -$370K -$338K -1054% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$801K -$439K -$298K -211% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$503K -$25.5K -$17.5K -219% Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-19
Q3 2020 -$485K -$304K -$296K -3706% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$189K -$32.1K -$24.1K -301% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-20
Q1 2020 -$165K -$141K -$133K -1661% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$32K -$8K -$1K -14.3% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-19
Q3 2019 -$31K -$8K +$4K +33.3% Jun 1, 2019 Aug 31, 2019 10-Q 2020-10-20
Q2 2019 -$35K -$8K +$13K +61.9% Mar 1, 2019 May 31, 2019 10-Q 2020-07-20
Q1 2019 -$48K -$8K -$17K -189% Dec 1, 2018 Feb 28, 2019 10-KT 2021-04-23
Q4 2018 -$31K -$7K +$15K +68.2% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-13
Q3 2018 -$46K -$12K +$10K +45.5% Jun 1, 2018 Aug 31, 2018 10-Q 2019-10-11
Q2 2018 -$56K -$21K +$2K +8.7% Mar 1, 2018 May 31, 2018 10-Q 2019-07-11
Q1 2018 -$58K $9K +$104K Dec 1, 2017 Feb 28, 2018 10-K 2019-06-12
Q4 2017 -$162K -$22K +$2K +8.33% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-11
Q3 2017 -$164K -$22K -$8K -57.1% Jun 1, 2017 Aug 31, 2017 10-Q 2018-10-12
Q2 2017 -$156K -$23K -$7K -43.8% Mar 1, 2017 May 31, 2017 10-Q 2018-07-16
Q1 2017 -$149K -$95K -$82K -631% Dec 1, 2016 Feb 28, 2017 10-K 2018-06-13
Q4 2016 -$67K -$24K -$10K -71.4% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-16
Q3 2016 -$57K -$14K +$7K +33.3% Jun 1, 2016 Aug 31, 2016 10-Q 2017-10-16
Q2 2016 -$64K -$16K -$1K -6.67% Mar 1, 2016 May 31, 2016 10-Q 2017-07-14
Q1 2016 -$63K -$13K -$1K -8.33% Dec 1, 2015 Feb 29, 2016 10-K 2017-06-14
Q4 2015 -$62K -$14K +$3K +17.6% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-13
Q3 2015 -$65K -$21K -$7K -50% Jun 1, 2015 Aug 31, 2015 10-Q 2016-10-12
Q2 2015 -$58K -$15K $0 0% Mar 1, 2015 May 31, 2015 10-Q 2016-07-12
Q1 2015 -$58K -$12K +$2K +14.3% Dec 1, 2014 Feb 28, 2015 10-K 2016-06-10
Q4 2014 -$60K -$17K -$3K -21.4% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-14
Q3 2014 -$57K -$14K $0 0% Jun 1, 2014 Aug 31, 2014 10-Q 2015-10-06
Q2 2014 -$57K -$15K -$2K -15.4% Mar 1, 2014 May 31, 2014 10-Q 2015-07-09
Q1 2014 -$55K -$14K $0 0% Dec 1, 2013 Feb 28, 2014 10-K 2015-06-15
Q4 2013 -$55K -$14K +$5K +26.3% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-14
Q3 2013 -$60K -$14K $0 0% Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-17
Q2 2013 -$60K -$13K $0 0% Mar 1, 2013 May 31, 2013 10-Q 2014-06-23
Q1 2013 -$60K -$14K -$5K -55.6% Dec 1, 2012 Feb 28, 2013 10-K 2014-06-06
Q4 2012 -$55K -$19K -$6K -46.2% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q3 2012 -$49K -$14K -$3K -27.3% Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-03
Q2 2012 -$46K -$13K +$1K +7.14% Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
Q1 2012 -$47K -$9K Dec 1, 2011 Feb 29, 2012 10-K 2013-06-12
Q4 2011 -$13K $0 0% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-16
Q3 2011 -$11K Jun 1, 2011 Aug 31, 2011 10-Q 2012-10-16
Q2 2011 -$14K Mar 1, 2011 May 31, 2011 10-Q 2012-07-12
Q4 2010 -$13K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.